cjc-1295 + ipamorelin combo Tesamorelin & (Mod GRF 1-29) & (12mg) Ipamorelin Cjc 1295 Protocol

Disclosures: Michael Thornton: ENDRA Life Sciences Inc: Employee, Jang Hwan Cho: Endra Life Sciences, Inc.: Employee, Idan Steinberg: Nothing to Disclose, Jing Gao: Nothing to Disclose, Colby Adamson: Nothing to Disclose 838 DIFFERENTIAL IMPACTS OF GLP1R GENE VARIANTS ON DISEASE RISK AND TREATMENT EFFICACY IN AFRICAN AMERICANS Eleonora Scorletti 1 Helen Huang 1 David Zhang 1 Marijana Vujkovic 1 Joseph Park 1 Florian Kahles 2 Giorgio Sirugo 1 Michael Phillips 1 Kai Markus Schneider 2 Garret FitzGerald 1 Daniel Rader 1 Carolin Schneider 2 , 1 University of Pennsylvania, 2 University of Aachen Background: Previous studies in European cohorts have established associations between single nucleotide polymorphisms (SNPs) in the glucagon-like peptide 1 receptor gene (GLP1R) and both obesity and type 2 diabetes (T2D), conditions characterized by a fundamental insulin resistance

The plate was incubated at room temperature for 510 min, before luminescence was measured using a Victor 3 1420 Multilabel Counter (Wallac 1420 Workstation, version 3.00 revision 5

Standard doses of 30-100 mcg work well with either morning or evening timing, while higher therapeutic doses may benefit from different approaches

101, 75D86D

The scavenging ability of Deu@PEPS in HaCaT was evaluated after co-stimulated with TNF- + IL-17A for 24 h by T-AOC and SOD